OBJECTIVE: Catechol O-methyltransferase (COMT) is an enzyme that inactivates catecholamines. Two common COMT alleles determine high and low activity of the enzyme. Previous studies using biochemical methods found lower enzyme activity in patients with major depression and bipolar disorder in comparison with control values, suggesting that a dysfunction in catecholamine metabolism may be related to the etiology of depression. METHOD: The authors studied two recently described DNA polymorphisms at the COMT gene (a silent C256G mutation and a structural mutation, Val-108-Met) in 88 patients with bipolar disorder and in 113 healthy comparison subjects, all of Spanish origin. RESULTS: The frequency of the C256 allele was 0.58 in the patients and 0.54 in the comparison subjects. The frequency of the Val108 variant was 0.57 for both the patients and the comparison subjects. No allelic or genotypic associations were observed. CONCLUSIONS: The lack of association suggests that the COMT gene is not a major risk factor for bipolar disorder.
OBJECTIVE:Catechol O-methyltransferase (COMT) is an enzyme that inactivates catecholamines. Two common COMT alleles determine high and low activity of the enzyme. Previous studies using biochemical methods found lower enzyme activity in patients with major depression and bipolar disorder in comparison with control values, suggesting that a dysfunction in catecholamine metabolism may be related to the etiology of depression. METHOD: The authors studied two recently described DNA polymorphisms at the COMT gene (a silent C256G mutation and a structural mutation, Val-108-Met) in 88 patients with bipolar disorder and in 113 healthy comparison subjects, all of Spanish origin. RESULTS: The frequency of the C256 allele was 0.58 in the patients and 0.54 in the comparison subjects. The frequency of the Val108 variant was 0.57 for both the patients and the comparison subjects. No allelic or genotypic associations were observed. CONCLUSIONS: The lack of association suggests that the COMT gene is not a major risk factor for bipolar disorder.
Authors: Stacy S Drury; Katherine P Theall; Anna T Smyke; Bronya J B Keats; Helen L Egger; Charles A Nelson; Nathan A Fox; Peter J Marshall; Charles H Zeanah Journal: Child Abuse Negl Date: 2010-04-18
Authors: M Karayiorgou; M Altemus; B L Galke; D Goldman; D L Murphy; J Ott; J A Gogos Journal: Proc Natl Acad Sci U S A Date: 1997-04-29 Impact factor: 11.205
Authors: Paula Rovira; Blanca Gutiérrez; Antonio Sorlózano-Puerto; José Gutiérrez-Fernández; Esther Molina; Margarita Rivera; Rafael Martínez-Leal; Inmaculada Ibanez-Casas; María Victoria Martín-Laguna; Araceli Rosa; Francisco Torres-González; Jorge A Cervilla Journal: Genes (Basel) Date: 2022-06-18 Impact factor: 4.141
Authors: Marco Bortolato; Consuelo Walss-Bass; Peter M Thompson; Jackob Moskovitz Journal: World J Biol Psychiatry Date: 2016-07-26 Impact factor: 4.132
Authors: Fayaz Seifuddin; Pamela Belmonte Mahon; Jennifer Judy; Mehdi Pirooznia; Dubravka Jancic; Jacob Taylor; Fernando S Goes; James B Potash; Peter P Zandi Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2012-05-09 Impact factor: 3.568